Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
11:06am, Wednesday, 16'th Apr 2025
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
12:36pm, Friday, 28'th Mar 2025
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain AMED Stock in Your Portfolio Now
12:26pm, Wednesday, 19'th Mar 2025
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
07:15am, Monday, 03'rd Mar 2025
Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
10:00pm, Wednesday, 26'th Feb 2025
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compa
Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates
06:50pm, Wednesday, 26'th Feb 2025
Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago.
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
04:30pm, Wednesday, 26'th Feb 2025
BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024.
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
11:06am, Wednesday, 12'th Feb 2025
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys Honors 47 Employees With Annual Spirit of Excellence Award
06:30am, Monday, 03'rd Feb 2025
BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the presti
3 Stocks to Gain From Trump's Family Caregiver Tax Credits
07:23am, Wednesday, 29'th Jan 2025
President Trump has endorsed the passage of a tax credit for family caregivers. The tax credit would be given to caregivers who take care of a parent, family member, or a loved one.
UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through
11:26am, Thursday, 09'th Jan 2025
UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.
Reasons to Retain AMED Stock in Your Portfolio Now
08:21am, Monday, 30'th Dec 2024
Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Midnight Sun Mining: illuminating the Zambian-Congo copperbelt with pursuit of high-value deposits
05:30am, Saturday, 28'th Dec 2024
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) and Amedisys (NASDAQ:AMED) have agreed to extend the deadline for their $3.3 billion merger, facing ongoing scrutiny from the US Department of Justice (DOJ).
Midnight Sun Mining secures Kazhiba target license renewal - ICYMI
05:30am, Saturday, 28'th Dec 2024
Midnight Sun Mining Corp (TSX-V:MMA, OTCQB:MDNGF) director of marketing and communications Adrian O'Brien talked with Proactive about securing approval from Zambia's Mines Ministry for the renewal of
UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny
02:45pm, Friday, 27'th Dec 2024
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) and Amedisys (NASDAQ:AMED) have agreed to extend the deadline for their $3.3 billion merger, facing ongoing scrutiny from the US Department of Justice (DOJ)
